Innate Pharma competitorsClear all
Innate Pharma's top competitors include Ablynx, Presage and Scimega.
 Innate Pharma Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. |  Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | |||
Founding Date | Founding Date 1999 | Founding Date 2001 | Founding Date 2008 | Founding Date 1997 |
Type | Type Public | Type Subsidiary | Type Private | Type Private |
Tags | ||||
Locations | Locations Marseille, FR HQ Rockville, US | Locations Gent, BE HQ | Locations Seattle, US HQ | Locations Laval, CA HQ |
Employees | Employees 212 | Employees 3293% decrease | Employees 1810% decrease | Employees 23 |
Twitter followers | Twitter followers 4 k | Twitter followers 282 | Twitter followers N/A | Twitter followers 1.2 k |
Alexa Website Rank | Alexa Website Rank N/A | Alexa Website Rank N/A | Alexa Website Rank 716726 | Alexa Website Rank 556620 |
Employee Rating | Employee Rating 4.1 | Employee Rating 3.3 | Employee Rating N/A | Employee Rating N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) €56.8m (FY, 2020) | Revenue (est.) €85.2m (FY, 2016) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income (€64m) (FY, 2020) | Net income (€1.1m) (FY, 2016) | Net income N/A | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 94.1m | Total funding raised $ 498.8m | Total funding raised $ 32.6m | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Ablynx
HQ
Gent, BE
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
View company
Presage
HQ
Seattle, US
Employees
18↓ 10% decrease
Presage is a biotech company developing a solution for the cancer drug development process.
View company